title: Uterine contraction frequency during treatment of pyelonephritis in pregnancy and subsequent risk of preterm birth.
abstract: OBJECTIVE
  To assess ceftriaxones effect on uterine contraction frequency and determine risk factors for subsequent preterm birth in women with pyelonephritis.
  
  
  METHODS
  Seventy-one women with pyelonephritis at greater than 24 weeks' gestation with continuous external tocodynamometry after antibiotic administration were studied. Patients received 2 doses of ceftriaxone 1 gram intramuscularly at 24-hour intervals. Temperatures, timing of antibiotic administration, and gestational age at delivery were recorded.
  
  
  RESULTS
  Uterine contraction frequency was measured for the hour prior to antibiotic administration, as well as the six hours after. Uterine activity steadily and significantly decreased from a mean of 5.1 +/- 7.3 at presentation to 2.0 +/- 2.9 uterine contractions per hour (P = .04, student t-test) six hours after ceftriaxone administration. The maximal number of contractions per hour each woman experienced did not correlate with temperature (r = .02, linear regression analysis). Uterine contractility and recurrent urinary tract infection were both associated with subsequent preterm birth (P = .004 and .016 respectively using nominal logistic regression analysis).
  
  
  CONCLUSIONS
  (1) A significant decrease in uterine activity from baseline occurs after ceftriaxone administration for acute pyelonephritis in pregnancy. (2) Temperature elevations are not associated with increased uterine activity. (3) Patients with significant uterine activity or recurrent urinary tract infection are at risk for preterm birth.
authors.affiliation: Kapiolani Medical Center for Women and Children, John A. Burns School of Medicine, University of Hawaii at Manoa, 1319 Punahou Street, Room 540 Honolulu, Hawaii 96826. LynnaeM@Kapiolani.org
authors.forename: Lynnae K
authors.initials: LK
authors.lastname: Millar
authors.forename: Laurie
authors.initials: L
authors.lastname: DeBuque
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Wing
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001831:Body Temperature; D005260:Female; D005440:Fluid Therapy; D005865:Gestational Age; D006801:Humans; D007958:Leukocyte Count; D008423:Maternal Age; D015999:Multivariate Analysis; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010298:Parity; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000628:therapy*; D011704:Pyelonephritis / Q000097:blood / Q000628:therapy*; D012044:Regression Analysis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013995:Time; D014590:Uterine Contraction / Q000502:physiology*; D018590:Uterine Monitoring / Q000379:methods
chemical_list: D000900:Anti-Bacterial Agents